Evidence map›Paper›PMID 37545233›Full record

ArticleJournal of Alzheimer's disease : JAD2023

Senescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice.

Pei Y Ng, Cheng Zhang, Hu Li, Darren J Baker

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Neuroinflammation in Alzheimer disease.Nature reviews. Immunology · 2025
    Review
  13. Article
  14. Senescent brain cell types in Alzheimer's disease: Pathological mechanisms and therapeutic opportunities.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Pei Y NgDepartment of Biochemistry and Molecular Biology.
Cheng ZhangDepartment of Molecular Pharmacology and Experimental Therapeutics.
Hu LiDepartment of Molecular Pharmacology and Experimental Therapeutics.
Darren J BakerDepartment of Biochemistry and Molecular Biology.
WinnMed · USMayo Clinic in Florida · US

Funding

The contribution of p16-expressing cells to tauopathyR01AG053229 · NIA · MAYO CLINIC ROCHESTER · PI BAKER, DARREN · 2017 to 2021
$2.0M
Effects of senescence to Alzheimer's disease pathologyR01AG068076 · NIA · MAYO CLINIC ROCHESTER · PI BAKER, DARREN · 2020 to 2024
$2.0M
NIA NIH HHS R01 AG053229NIA NIH HHS R01 AG068076
6 · The paper itself

Abstract

backgroundThe existence and contribution of microglia with senescent-like alterations in the pathogenesis of age-related neurodegenerative diseases like Alzheimer's disease (AD) have been suggested in recent years. However, the identification of this distinct microglial population in vivo has proven challenging, largely due to overlaps in the inflammatory phenotype of activated and senescent microglia. Furthermore, attempts at recapitulating senescence in microglia in vitro are limited.

objectiveTo identify and characterize senescent microglia that occur in vivo in an animal model of neurodegeneration driven by pathologic tau.

methodsWe analyzed the RNA expression patterns of individual microglia from normal mice and the pathogenic tau P301 S PS19 mouse model. We have previously demonstrated that p16-expressing senescent microglia occur in these mice when neurodegeneration has occurred.

resultsHere we identify a subset of disease-associated microglia with senescent features, notably characterized by the expression of Ccl4. This signature overlaps with established markers of senescence from other cell types.

conclusionOur characterization of senescent microglia can be used to better understand the role of senescent microglia in various age-related contexts, including whether clearance of senescent microglia represents a viable therapeutic option.

Indexed as

Alzheimer DiseaseMicrogliaAnimalsDisease Models, AnimalMiceMice, TransgenicPhenotypeAlzheimer’s diseasecellular senescencemicrogliatauopathy

Identifiers

PMID37545233
PMCPMC10848894
OpenAlexW4385575395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.